NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / India to miss July vaccination target over low COVAXIN supply
    India

    India to miss July vaccination target over low COVAXIN supply

    India to miss July vaccination target over low COVAXIN supply
    Written by Sagar
    Jul 26, 2021, 07:31 pm 3 min read
    India to miss July vaccination target over low COVAXIN supply
    India will miss its target to give out over 50 crore coronavirus vaccine doses by July.

    India will miss its target to give out over 500 million (50 crore) coronavirus vaccine shots by the end of July, mainly because of low supplies of COVAXIN, its only indigenous jab so far. India's ambitious COVID-19 vaccination drive has remained marred by supply issues and hesitancy among sections of the population. Here are more details on this.

    Government had said it would arrange 51.6cr doses by July

    In May, the Indian government had announced it would make 51.6 crore shots available by the end of this month. India has given out over 43 crore doses and it is currently administering an average of 45 lakh daily doses. The country would have to triple its daily vaccinations up to 1.4 crore to meet the target. But data suggests that will be impossible.

    Only 2.5 crore doses of COVAXIN supplied this month

    For the said projection, the government had been relying on 6 to 7 crore monthly doses of COVAXIN starting July or August. But Bharat Biotech, the company behind this vaccine, will be able to supply only 2.5 crore doses this month and 3.5 crore in August, Union Health Minister Mansukh Mandaviya had told the Parliament last week.

    India aims to inoculate all adults by December

    India aims to inoculate all adults - estimated to be 94.4 crore - by the end of this year. For that target, the government is counting on 50 crore doses of Covishield and some 40 crore doses of COVAXIN. Supplies of Russia's Sputnik V vaccine have remained limited. Meanwhile, doses of India's another approved jab, Moderna, may not arrive until next year, reports suggest.

    7% of Indians are fully vaccinated yet

    India has administered the most number of COVID-19 vaccines globally, after China, but its vaccination rate per population remains poor. Even though nearly 25% of Indians have received at least one vaccine shot, just about 7% have been fully inoculated as yet. Around 88% of all vaccine doses administered in India have been Covishield's, locally manufactured by the Serum Institute of India (SII).

    Zydus Cadila vaccine could be approved soon

    Indian drug firm Zydus Cadila had applied for the emergency use authorization of its vaccine earlier this month and an approval is expected soon. Separately, the country will likely start inoculating children against the coronavirus by September.

    India's coronavirus situation

    India had faced the world's worst coronavirus outbreak earlier this year, reporting lakhs of cases and thousands of deaths daily. The situation has since improved as the country has been reporting around 40,000 daily cases for the past few weeks. However, experts have warned that a third wave could hit India by the end of next month.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Health & Wellness
    Mansukh Mandaviya
    Coronavirus
    COVID-19

    Latest

    5 foods that can make your memory problems worse Food
    Flying with your cat? You should totally read this Pets
    Pakistan hikes petrol, diesel prices by PKR 35/liter amid crisis Pakistan
    JAWA 42 v/s Royal Enfield Classic 350: A comparison Royal Enfield Classic 350

    Health & Wellness

    Here are 5 signs you are consuming too much sugar Food
    From causes to treatment, here's everything to know about sinusitis Lifestyle
    Rakhi Sawant's mother dies battling cancer, last rites in Mumbai Rakhi Sawant
    Veteran Kannada actor Mandeep Roy passes away at 73 Kannada Films

    Mansukh Mandaviya

    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    Marion Biotech, linked to Uzbekistan kids' death, halts production   Ministry of Health and Family Welfare
    India mandates negative RT-PCR report for fliers from China, others RT-PCR Test
    Delhi: 39 international travelers test COVID-19 positive in 2 days COVID-19

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    COVID-19

    Have you heard about the travel trends for 2023 yet Travel And Tourism
    New Zealand: Chris Hipkins likely to be next Prime Minister  Jacinda Ardern
    Singapore: Trial against accused for racially abusing, kicking Indian woman Singapore
    US doubling embassy staff to expedite Indian visas: Reports United States of America

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023